Hospital/Health System
July 19, 2017
Updated IDSA/ATS Guidelines on Management of Adults With HAP and VAP
Pharmacists are in a key position to recommend de-escalation of antimicrobial therapy based on culture and sensitivity results and to ensure that patients are receiving the appropriate duration of therapy.
July 19, 2017
The Pharmacist’s Role in the Treatment and Prevention of Acute Mountain Sickness
Untreated, this condition, which is cased by travel to mountainous regions, can progress to high-altitude cerebral or pulmonary edema.
May 19, 2017
Hypophosphatasia: A Rare Disorder
Hypophosphatasia is a rare genetic metabolic disorder caused by mutations in the tissue nonspecific alkaline phosphatase gene (ALPL) that lead to defective mineralization of the bones and/or teeth.
May 19, 2017
Managing Lysosomal Acid Lipase Deficiency
When treating a complex genetic disorder like LAL-D, an interdisciplinary team approach can be beneficial and provides the best outcomes for patients.
April 21, 2017
Necrotizing Soft-Tissue Infection: Disease Overview and Updated Treatment Strategies
Necrotizing soft-tissue infections are a type of serious bacterial infection requiring rapid recognition and intervention in combination with timely antibiotic treatment.
April 21, 2017
Travel-Related Infection in Children: Pretravel Counseling to Reduce Morbidity
Travel-related infections affect children disproportionately and may lead to serious consequences; pharmacists can provide crucial pretravel information.
March 17, 2017
Treatment Options in Managing Acute Perioperative Pain
If the interventions and drugs employed perioperatively are inadequate, the pain could develop into a chronic problem or worsen patient outcomes.
March 17, 2017
Pearls and Pitfalls of Patient-Controlled Analgesia
Patient-controlled analgesia refers to the delivery of analgesics immediately upon patient demand.
February 16, 2017
Updated Treatment Options in the Management of Hyperkalemia
Patiromer was recently approved for chronic hyperkalemia, and other medications are in development.
